A carregar...
Can molecular biomarkers replace a clinical risk score for resectable colorectal liver metastasis?
In resectable colorectal liver metastasis (CRLM) the role and use of molecular biomarkers is still controversial. Several biomarkers have been linked to clinical outcomes in CRLM, but none have so far become routine for clinical decision making. For several reasons, the clinical risk score appears t...
Na minha lista:
| Publicado no: | World J Gastrointest Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5348630/ https://ncbi.nlm.nih.gov/pubmed/28344745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v9.i3.98 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|